Using small molecule GSK3β inhibitors to treat inflammation G Klamer, E Song, KH Ko, TA O'brien, A Dolnikov Current medicinal chemistry 17 (26), 2873-2881, 2010 | 60 | 2010 |
Glycogen synthase kinase− 3β inhibitors suppress leukemia cell growth EY Song, P Palladinetti, G Klamer, KH Ko, R Lindeman, TA O'Brien, ... Experimental hematology 38 (10), 908-921. e1, 2010 | 56 | 2010 |
Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia A Dolnikov, S Shen, G Klamer, S Joshi, N Xu, L Yang, K Micklethwaite, ... Experimental hematology 43 (12), 1001-1014. e5, 2015 | 25 | 2015 |
GSK‐3β inhibition promotes early engraftment of ex vivo‐expanded haematopoietic stem cells A Dolnikov, N Xu, S Shen, E Song, T Holmes, G Klamer, TA O'Brien Cell Proliferation 47 (2), 113-123, 2014 | 19 | 2014 |
Small-molecule inhibitor of glycogen synthase kinase 3β 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice S Shen, N Xu, G Klamer, KH Ko, M Khoo, D Ma, J Moore, TA O'Brien, ... Stem Cells and Development 24 (6), 724-736, 2015 | 17 | 2015 |
GSK3 inhibition prevents lethal GVHD in mice G Klamer, S Shen, E Song, AM Rice, R Knight, R Lindeman, TA O’Brien, ... Experimental Hematology 41 (1), 39-55. e10, 2013 | 16 | 2013 |
GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice S Shen, G Klamer, N Xu, TA O’Brien, A Dolnikov Experimental Hematology 41 (12), 1016-1027. e1, 2013 | 13 | 2013 |
Identification and re-consent of existing cord blood donors for creation of induced pluripotent stem cell lines for potential clinical applications KM Abberton, TL McDonald, M Diviney, R Holdsworth, S Leslie, ... Stem Cells Translational Medicine 11 (10), 1052-1060, 2022 | 6 | 2022 |
Identifying the factors modulating the efficacy of car-t cell therapy A Dolnikov, G Klamer, A Chitranjan, N Xu, S Shen, KP Micklethwaite, ... Blood 124 (21), 5813, 2014 | 3 | 2014 |
A comprehensive human leukocyte antigen analysis of 36 782 cord blood units stored in the Australian Public Cord Blood Banking Network G Klamer, J Sue, A Trickett, KH Ko, P Johnson, NJ Elwood Cytotherapy 24 (10), 990-998, 2022 | 1 | 2022 |
Evaluation of the MacoPress SMART Blood Component Separator for Volume Reduction of Cord Blood Units in a Multicenter Validation Study P Johnson, S Massa, M Villacres, R Rodwell, N Elwood, J Youngson, ... Stem Cells Translational Medicine 7 (S1), S17-S17, 2018 | 1 | 2018 |
Regulatory Affairs, Quality Systems, Policy, and Ethics: A SYSTEMATIC APPROACH TO THE CONTROL, DETECTION AND MONITORING OF MICROBIAL CONTAMINATION DURING CORD BLOOD MANUFACTURE … J Sue, K Ko, G Klamer Cytotherapy 25 (6), S165, 2023 | | 2023 |
Abstract 26 HLA Analysis of the Australian Cord Blood Banks: How Diverse Are Donors? G Klamer, J Sue, KH Ko, A Trickett, P Johnson, N Elwood Stem Cells Translational Medicine 11 (Supplement_1), S31-S31, 2022 | | 2022 |
A Dual Center Validation of a Manufacturing Database J Sue, L Liu, A Deeming, R Avard, S De, D Tsoutras, F Pratt, KH Ko, ... Stem Cells Translational Medicine 10 (S1), S16-S16, 2021 | | 2021 |
The Sydney Cord Blood Bank Stability Monitoring Program G Klamer, J Sue, M Araya, KY Ko, U Chaudhari, M Villacres, KH Ko Stem Cells Translational Medicine 10 (S1), S17-S17, 2021 | | 2021 |
Increase in Cord Blood Transplant-Related Activities Across the AusCord Network due to COVID-19 N Elwood, G Klamer, P Johnson Stem Cells Translational Medicine 9 (S1), S17-S17, 2020 | | 2020 |
Enumeration of primitive haematopoietic progenitor cells to improve the quality of cord blood product testing K Ko, G Klamer, A Trickett, J Youngson Cytotherapy 21 (5), S54, 2019 | | 2019 |
Transition and Implementation of Nationally Aligned Operations for Australian AusCord Public Cord Blood Banks R Rodwell, J Youngson, N Elwood, A Montague, P Johnson, M Villacres, ... Stem Cells Translational Medicine 7 (S1), S14-S14, 2018 | | 2018 |
The relationship between CD133+ CD34-cells and CD34+ haematopoietic progenitor cells in cord blood KH Ko, G Klamer, A Trickett, J Youngson BONE MARROW TRANSPLANTATION 53, 524-525, 2018 | | 2018 |
A Multi-Center Validation for the Microbiologic Screening of Hematopoietic Progenitor Cells Cord Blood S Massa, P Johnson, M Villacres, A Deeming, J Ramsay, G Klamer, ... Stem Cells Translational Medicine 7 (S1), S16-S16, 2018 | | 2018 |